Annual EBITDA:
$600.00M-$316.70M(-34.55%)Summary
- As of today, DXCM annual EBITDA is $600.00 million, with the most recent change of -$316.70 million (-34.55%) on December 31, 2024.
- During the last 3 years, DXCM annual EBITDA has risen by +$222.40 million (+58.90%).
- DXCM annual EBITDA is now -34.55% below its all-time high of $916.70 million, reached on December 31, 2023.
Performance
DXCM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$306.10M+$30.50M(+11.07%)Summary
- As of today, DXCM quarterly EBITDA is $306.10 million, with the most recent change of +$30.50 million (+11.07%) on September 30, 2025.
- Over the past year, DXCM quarterly EBITDA has increased by +$98.80 million (+47.66%).
- DXCM quarterly EBITDA is now at all-time high.
Performance
DXCM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.02B+$98.80M(+10.70%)Summary
- As of today, DXCM TTM EBITDA is $1.02 billion, with the most recent change of +$98.80 million (+10.70%) on September 30, 2025.
- Over the past year, DXCM TTM EBITDA has increased by +$181.70 million (+21.62%).
- DXCM TTM EBITDA is now at all-time high.
Performance
DXCM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DXCM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -34.5% | +47.7% | +21.6% |
| 3Y3 Years | +58.9% | +64.0% | +144.5% |
| 5Y5 Years | +181.4% | +172.1% | +185.5% |
DXCM EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -34.5% | +58.9% | at high | +244.7% | at high | +144.5% |
| 5Y | 5-Year | -34.5% | +181.4% | at high | +836.1% | at high | +185.5% |
| All-Time | All-Time | -34.5% | +903.2% | at high | +296.2% | at high | +750.2% |
DXCM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $306.10M(+11.1%) | $1.02B(+10.7%) |
| Jun 2025 | - | $275.60M(+42.3%) | $923.30M(+7.6%) |
| Mar 2025 | - | $193.70M(-21.5%) | $857.80M(+4.9%) |
| Dec 2024 | $600.00M(-34.5%) | $246.70M(+19.0%) | $817.70M(-2.7%) |
| Sep 2024 | - | $207.30M(-1.3%) | $840.40M(-5.2%) |
| Jun 2024 | - | $210.10M(+36.8%) | $886.80M(+4.5%) |
| Mar 2024 | - | $153.60M(-43.0%) | $848.50M(+8.3%) |
| Dec 2023 | $916.70M(+62.2%) | $269.40M(+6.2%) | $783.70M(+15.9%) |
| Sep 2023 | - | $253.70M(+47.7%) | $676.00M(+11.0%) |
| Jun 2023 | - | $171.80M(+93.5%) | $609.00M(+9.2%) |
| Mar 2023 | - | $88.80M(-45.1%) | $557.80M(+2.0%) |
| Dec 2022 | $565.30M(+49.7%) | $161.70M(-13.4%) | $547.10M(+30.9%) |
| Sep 2022 | - | $186.70M(+54.8%) | $418.10M(+11.4%) |
| Jun 2022 | - | $120.60M(+54.4%) | $375.20M(-1.0%) |
| Mar 2022 | - | $78.10M(+138.8%) | $379.10M(+3.1%) |
| Dec 2021 | $377.60M(+0.2%) | $32.70M(-77.3%) | $367.80M(-20.0%) |
| Sep 2021 | - | $143.80M(+15.5%) | $459.50M(+7.3%) |
| Jun 2021 | - | $124.50M(+86.4%) | $428.20M(+10.7%) |
| Mar 2021 | - | $66.80M(-46.3%) | $386.80M(+5.5%) |
| Dec 2020 | $376.80M(+76.7%) | $124.40M(+10.6%) | $366.60M(+2.4%) |
| Sep 2020 | - | $112.50M(+35.4%) | $358.00M(+13.9%) |
| Jun 2020 | - | $83.10M(+78.3%) | $314.40M(+29.9%) |
| Mar 2020 | - | $46.60M(-59.8%) | $242.10M(+26.8%) |
| Dec 2019 | $213.20M(+385.4%) | $115.80M(+68.1%) | $191.00M(+336.4%) |
| Sep 2019 | - | $68.90M(+538.0%) | -$80.80M(+36.9%) |
| Jun 2019 | - | $10.80M(+340.0%) | -$128.00M(+6.6%) |
| Mar 2019 | - | -$4.50M(+97.1%) | -$137.00M(+12.8%) |
| Dec 2018 | -$74.70M(-279.2%) | -$156.00M(-818.9%) | -$157.20M(-1148.0%) |
| Sep 2018 | - | $21.70M(+1105.6%) | $15.00M(+617.2%) |
| Jun 2018 | - | $1.80M(+107.3%) | -$2.90M(+79.9%) |
| Mar 2018 | - | -$24.70M(-252.5%) | -$14.40M(+45.5%) |
| Dec 2017 | -$19.70M(+60.0%) | $16.20M(+326.3%) | -$26.40M(+41.5%) |
| Sep 2017 | - | $3.80M(+139.2%) | -$45.10M(+28.8%) |
| Jun 2017 | - | -$9.70M(+73.6%) | -$63.30M(+9.3%) |
| Mar 2017 | - | -$36.70M(-1368.0%) | -$69.80M(-42.7%) |
| Dec 2016 | -$49.20M(-6.3%) | -$2.50M(+82.6%) | -$48.90M(-17.3%) |
| Sep 2016 | - | -$14.40M(+11.1%) | -$41.70M(+37.8%) |
| Jun 2016 | - | -$16.20M(-2.5%) | -$67.00M(-29.3%) |
| Mar 2016 | - | -$15.80M(-436.2%) | -$51.80M(-11.9%) |
| Dec 2015 | -$46.30M(-253.4%) | $4.70M(+111.8%) | -$46.30M(+1.5%) |
| Sep 2015 | - | -$39.70M(-3870.0%) | -$47.00M(-327.3%) |
| Jun 2015 | - | -$1.00M(+90.3%) | -$11.00M(+26.2%) |
| Mar 2015 | - | -$10.30M(-357.5%) | -$14.90M(-8.0%) |
| Dec 2014 | -$13.10M | $4.00M(+208.1%) | -$13.80M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | -$3.70M(+24.5%) | -$17.70M(-3.5%) |
| Jun 2014 | - | -$4.90M(+46.7%) | -$17.10M(+19.3%) |
| Mar 2014 | - | -$9.20M(-9300.0%) | -$21.20M(-0.5%) |
| Dec 2013 | -$21.90M(+55.3%) | $100.00K(+103.2%) | -$21.10M(+24.0%) |
| Sep 2013 | - | -$3.10M(+65.6%) | -$27.78M(+30.2%) |
| Jun 2013 | - | -$9.00M(+1.1%) | -$39.80M(+9.5%) |
| Mar 2013 | - | -$9.10M(-38.3%) | -$43.98M(+10.4%) |
| Dec 2012 | -$49.00M(-19.8%) | -$6.58M(+56.5%) | -$49.10M(+8.6%) |
| Sep 2012 | - | -$15.12M(-14.7%) | -$53.73M(-5.5%) |
| Jun 2012 | - | -$13.18M(+7.3%) | -$50.92M(-15.1%) |
| Mar 2012 | - | -$14.21M(-26.8%) | -$44.23M(-7.7%) |
| Dec 2011 | -$40.90M(+20.3%) | -$11.21M(+8.9%) | -$41.08M(-5.2%) |
| Sep 2011 | - | -$12.31M(-89.5%) | -$39.04M(+0.3%) |
| Jun 2011 | - | -$6.50M(+41.3%) | -$39.16M(+9.7%) |
| Mar 2011 | - | -$11.06M(-20.7%) | -$43.34M(-1.1%) |
| Dec 2010 | -$51.30M(-19.0%) | -$9.16M(+26.3%) | -$42.85M(-0.4%) |
| Sep 2010 | - | -$12.43M(-16.4%) | -$42.68M(-3.5%) |
| Jun 2010 | - | -$10.68M(-1.0%) | -$41.24M(+4.9%) |
| Mar 2010 | - | -$10.57M(-17.6%) | -$43.35M(+0.3%) |
| Dec 2009 | -$43.11M(+13.4%) | -$8.99M(+18.2%) | -$43.46M(+6.4%) |
| Sep 2009 | - | -$10.99M(+14.1%) | -$46.44M(+4.7%) |
| Jun 2009 | - | -$12.79M(-19.7%) | -$48.73M(-0.1%) |
| Mar 2009 | - | -$10.69M(+10.7%) | -$48.69M(+2.2%) |
| Dec 2008 | -$49.79M(-14.9%) | -$11.97M(+9.9%) | -$49.79M(-1.6%) |
| Sep 2008 | - | -$13.28M(-4.1%) | -$48.99M(-5.2%) |
| Jun 2008 | - | -$12.75M(-8.2%) | -$46.58M(-4.2%) |
| Mar 2008 | - | -$11.79M(-5.5%) | -$44.72M(-2.2%) |
| Dec 2007 | -$43.34M(+7.0%) | -$11.17M(-2.8%) | -$43.76M(-1.1%) |
| Sep 2007 | - | -$10.87M(+0.3%) | -$43.28M(+6.1%) |
| Jun 2007 | - | -$10.89M(-0.6%) | -$46.07M(+1.0%) |
| Mar 2007 | - | -$10.83M(-1.4%) | -$46.53M(-4.4%) |
| Dec 2006 | -$46.62M(-48.6%) | -$10.69M(+21.8%) | -$44.56M(+3.3%) |
| Sep 2006 | - | -$13.66M(-20.2%) | -$46.10M(-18.3%) |
| Jun 2006 | - | -$11.36M(-28.3%) | -$38.95M(-15.3%) |
| Mar 2006 | - | -$8.86M(+27.6%) | -$33.79M(-9.3%) |
| Dec 2005 | -$31.36M(-131.0%) | -$12.23M(-87.7%) | -$30.91M(-65.4%) |
| Sep 2005 | - | -$6.52M(-5.2%) | -$18.68M(-53.6%) |
| Jun 2005 | - | -$6.19M(-3.6%) | -$12.17M(-103.6%) |
| Mar 2005 | - | -$5.97M | -$5.97M |
| Dec 2004 | -$13.58M(-38.1%) | - | - |
| Dec 2003 | -$9.83M(-55.8%) | - | - |
| Dec 2002 | -$6.31M(+6.1%) | - | - |
| Dec 2001 | -$6.72M(-67.5%) | - | - |
| Dec 2000 | -$4.01M | - | - |
FAQ
- What is DexCom, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for DexCom, Inc.?
- What is DexCom, Inc. annual EBITDA year-on-year change?
- What is DexCom, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for DexCom, Inc.?
- What is DexCom, Inc. quarterly EBITDA year-on-year change?
- What is DexCom, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for DexCom, Inc.?
- What is DexCom, Inc. TTM EBITDA year-on-year change?
What is DexCom, Inc. annual EBITDA?
The current annual EBITDA of DXCM is $600.00M
What is the all-time high annual EBITDA for DexCom, Inc.?
DexCom, Inc. all-time high annual EBITDA is $916.70M
What is DexCom, Inc. annual EBITDA year-on-year change?
Over the past year, DXCM annual EBITDA has changed by -$316.70M (-34.55%)
What is DexCom, Inc. quarterly EBITDA?
The current quarterly EBITDA of DXCM is $306.10M
What is the all-time high quarterly EBITDA for DexCom, Inc.?
DexCom, Inc. all-time high quarterly EBITDA is $306.10M
What is DexCom, Inc. quarterly EBITDA year-on-year change?
Over the past year, DXCM quarterly EBITDA has changed by +$98.80M (+47.66%)
What is DexCom, Inc. TTM EBITDA?
The current TTM EBITDA of DXCM is $1.02B
What is the all-time high TTM EBITDA for DexCom, Inc.?
DexCom, Inc. all-time high TTM EBITDA is $1.02B
What is DexCom, Inc. TTM EBITDA year-on-year change?
Over the past year, DXCM TTM EBITDA has changed by +$181.70M (+21.62%)